To evaluate this possibility, CTL-refractory NYESO1+ A375 P3 tumor-bearing NOD-SCID mice were administered the NYESO1-specific CD8+ T cells alone or combined with simvastatin (Fig. 7a). The gene discussed is CD8A; the disease is neoplasm.